Cargando…
Natural Products as Potential Lead Compounds for Drug Discovery Against SARS-CoV-2
For the past 2 years, the coronavirus responsible for the COVID-19 infection has become a world pandemic, ruining the lives and economies of several nations in the world. This has scaled up research on the virus and the resulting infection with the goal of developing new vaccines and therapies. Natu...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435765/ https://www.ncbi.nlm.nih.gov/pubmed/34515981 http://dx.doi.org/10.1007/s13659-021-00317-w |
_version_ | 1783751866822164480 |
---|---|
author | Ebob, Oyere Tanyi Babiaka, Smith B. Ntie-Kang, Fidele |
author_facet | Ebob, Oyere Tanyi Babiaka, Smith B. Ntie-Kang, Fidele |
author_sort | Ebob, Oyere Tanyi |
collection | PubMed |
description | For the past 2 years, the coronavirus responsible for the COVID-19 infection has become a world pandemic, ruining the lives and economies of several nations in the world. This has scaled up research on the virus and the resulting infection with the goal of developing new vaccines and therapies. Natural products are known to be a rich source of lead compounds for drug discovery, including against infectious diseases caused by microbes (viruses, bacteria and fungi). In this review article, we conducted a literature survey aimed at identifying natural products with inhibitory concentrations against the coronaviruses or their target proteins, which lie below 10 µM. This led to the identification of 42 compounds belonging to the alkaloid, flavonoid, terpenoid, phenolic, xanthone and saponin classes. The cut off concentration of 10 µM was to limit the study to the most potent chemical entities, which could be developed into therapies against the viral infection to make a contribution towards limiting the spread of the disease. |
format | Online Article Text |
id | pubmed-8435765 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-84357652021-09-13 Natural Products as Potential Lead Compounds for Drug Discovery Against SARS-CoV-2 Ebob, Oyere Tanyi Babiaka, Smith B. Ntie-Kang, Fidele Nat Prod Bioprospect Review For the past 2 years, the coronavirus responsible for the COVID-19 infection has become a world pandemic, ruining the lives and economies of several nations in the world. This has scaled up research on the virus and the resulting infection with the goal of developing new vaccines and therapies. Natural products are known to be a rich source of lead compounds for drug discovery, including against infectious diseases caused by microbes (viruses, bacteria and fungi). In this review article, we conducted a literature survey aimed at identifying natural products with inhibitory concentrations against the coronaviruses or their target proteins, which lie below 10 µM. This led to the identification of 42 compounds belonging to the alkaloid, flavonoid, terpenoid, phenolic, xanthone and saponin classes. The cut off concentration of 10 µM was to limit the study to the most potent chemical entities, which could be developed into therapies against the viral infection to make a contribution towards limiting the spread of the disease. Springer Singapore 2021-09-13 /pmc/articles/PMC8435765/ /pubmed/34515981 http://dx.doi.org/10.1007/s13659-021-00317-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Ebob, Oyere Tanyi Babiaka, Smith B. Ntie-Kang, Fidele Natural Products as Potential Lead Compounds for Drug Discovery Against SARS-CoV-2 |
title | Natural Products as Potential Lead Compounds for Drug Discovery Against SARS-CoV-2 |
title_full | Natural Products as Potential Lead Compounds for Drug Discovery Against SARS-CoV-2 |
title_fullStr | Natural Products as Potential Lead Compounds for Drug Discovery Against SARS-CoV-2 |
title_full_unstemmed | Natural Products as Potential Lead Compounds for Drug Discovery Against SARS-CoV-2 |
title_short | Natural Products as Potential Lead Compounds for Drug Discovery Against SARS-CoV-2 |
title_sort | natural products as potential lead compounds for drug discovery against sars-cov-2 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435765/ https://www.ncbi.nlm.nih.gov/pubmed/34515981 http://dx.doi.org/10.1007/s13659-021-00317-w |
work_keys_str_mv | AT eboboyeretanyi naturalproductsaspotentialleadcompoundsfordrugdiscoveryagainstsarscov2 AT babiakasmithb naturalproductsaspotentialleadcompoundsfordrugdiscoveryagainstsarscov2 AT ntiekangfidele naturalproductsaspotentialleadcompoundsfordrugdiscoveryagainstsarscov2 |